Hajime has over 20+ years of experience in the medical device industry, including venture capital and operating companies. He started medical device investment to U.S. startups from Tokyo in 1997 and then was hired by a VC in Silicon Valley in 2005 soon after successful exit of an investment to a U.S. start-up.
Innovative products developed by portfolio companies are saving patients worldwide such as Pipeline Fowdiverter Stent, developed by Chestnut Medical, the first treatment device for giant intracranial aneurysms.
After 5 years of medical device investment in the U.S., he founded MedVenture Partners, Inc., in 2013, a VC focused on medical device, and established 1st investment fund (6 billion Yen) Japan and 2nd investment fund (99 billion Yen) in 2020. He holds number of board positions in portfolio companies and achieved multiple successful exits in Japan as well, such as Biomedical Solutions, Inc. and A-Traction, Inc.